Direct-to-consumer medical testing in the era of value-based care

JAMA - Journal of the American Medical Association

Volumn 317, Issue 24, 2017, Pages 2485-2486

  Rockwell, Kimberly Lovett ^a  

^a Honigman Miller Schwartz and Cohn LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST CONTROL; DIRECT-TO-CONSUMER ADVERTIZING; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; LABORATORY TEST; LAW; PATIENT CARE; PATIENT SAFETY; PHYSICIAN; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES; ECONOMICS; GENETIC SCREENING; HEALTH SERVICE; LEGISLATION AND JURISPRUDENCE; PREVENTION AND CONTROL; SCREENING TEST; STANDARDS; TRENDS; UNNECESSARY PROCEDURE;

COST CONTROL; DELIVERY OF HEALTH CARE; DIRECT-TO-CONSUMER SCREENING AND TESTING; GENETIC TESTING; HEALTH CARE COSTS; HEALTH SERVICES MISUSE; HUMANS; QUALITY OF HEALTH CARE; STATE GOVERNMENT; UNITED STATES; UNITED STATES FEDERAL TRADE COMMISSION; UNITED STATES FOOD AND DRUG ADMINISTRATION; UNNECESSARY PROCEDURES;

EID: 85021255927     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.5929     Document Type: Short Survey

References (7)

1. Obama B. United States health care reform: progress to date and next steps. JAMA. 2016;316(5):525-532.
2. Lovett KM, Mackey TK, Liang BA. Evaluating the evidence: direct-to-consumer screening tests advertised online. J Med Screen. 2012;19(3):141-153.
3. Keshavan M. 20 Key players in the direct-to-consumer lab testing market. MedCity News. http://medcitynews.com/2016/01/20-key-players-in-the-direct-to-consumer-lab-testing-market/. Published January 20, 2016. Accessed April 18, 2017.
4. McGuire AL, Burke W. Health system implications of direct-to-consumer personal genome testing. Public Health Genomics. 2011;14(1):53-58.
5. US Food and Drug Administration. FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm551185.htm. Posted April 6, 2017. Accessed April 18, 2017.
6. Kaufman DJ, Bollinger JM, Dvoskin RL, Scott JA. Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing. J Genet Couns. 2012;21(3):413-422.
7. Zafar HM, Bugos EK, Langlotz CP, Frasso R. "Chasing a ghost": factors that influence primary care physicians to follow up on incidental imaging findings. Radiology. 2016;281(2):567-573.